alexa Role of Chemokine Signalling in the Pathogenesis of Goo
ISSN: 1745-7580

Immunome Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Role of Chemokine Signalling in the Pathogenesis of Good's Syndrome-Case Reports, Clinical Characterization from Single-Centre Perspective

Przemyslaw Zdziarski1,4*, Grzegorz Dworacki2, Agnieszka Korzeniowska-Kowal4 and Katarzyna Ziemnicka3

1Department of Clinical Immuno-oncology, Lower Silesian Center, Poland

2Department of Immunology, Lower Silesian Center, Poland

3Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland

4Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland

*Corresponding Author:
Przemyslaw Zdziarski
Department of Clinical Immuno-oncology
Lower Silesian Center P.O Box 1818 50-385
Wrocław-46, Poland
Tel: +48-618547174
Fax: +48-61 8547173
E-mail: [email protected]

Received date: June 26, 2016; Accepted date: August 11, 2016; Published date: August 16, 2016

Citation: Zdziarski P, Dworacki G, Kowal AK, Ziemnicka K (2016) Role of Chemokine Signalling in the Pathogenesis of Good’s Syndrome-Case Reports, Clinical Characterization from Single-Centre Perspective. Immunome Res 12:119. doi: 10.4172/1745-7580.10000119

Copyright: © 2016 Zdziarski P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Good’s syndrome (GS), is a rare condition defined as a coexistence of thymoma and hipogammaglobulinaemia. Involvement of central lymphoid organ prompts concept about perturbation in lymphocyte migration and differentiation. Cell homing to bone marrow compartment depends on the CXCR4↔CXCL12 interaction. In this paper we describe two patients with GS-mild and severe form, presenting differences in the expression of CXCR4 on cells in peripheral blood and bone marrow. Patient 1 (mild form): (i) Mild hipogammaglobulinaemia (IgG=150 mg/dL), (ii) Low count of peripheral B cells (14%, 60 cells/μL) and NK (18%, 77cells/μL); high level of T cells (93.3%, 4006 cells/ μL), (iii) Moderate thymic enlargement (9 × 15 cm), (iv) CXCR4 expression in BM 82.6% (20139/μL), 34% CXCR4+CD19+ (8289/μL). Patient 2 (severe form): (i) Severe hipogammaglobulinaemia (IgG=20 mg/dL), (ii) Absence of B and NK cells deficiency (in peripheral blood 0.4% i.e., 10/μL, and 6.17%-47.3/μL respectively), (iii) Severe thymic enlargement (20 × 25 cm) (iv) CXCR4 expression in BM 46.3% (552/μL); 6.1%, CXCR4+CD19+ (174/ μL). Interestingly, the bone marrow of patient with severe form of GS contained more CD10-positive B cells than BM of the patient with mild form (80% vs. 5.88% of B cells), but in former as well as letter a significant proportion of the total CXCR4-positive lymphocytes are negative for B cells marker (comparable: 48.1% and 53.1% respectively). In our patients a tenfold decrease in the CD4-positive γδ T cells (CD4+TCRγδ) counts was observed. Both cases went up fatal due to progression of nasopharyngeal cancer (mild form) and breast cancer (severe form). This data confirm that earliest B cell precursors, pre-pro-B cells and end-stage B cells, plasma cells require CXCR4 ↔ CXCL12 interaction. In contrast in GS weak expression of CXCR4 in marrow precursors is source of B cell differentiation arrest on pro-B cell stage. The low level Nk and CD4+γδ T cells in Good syndrome is the new observation.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version